Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nerea M. Herrera‐Casanova
Observed names:
Nerea Herrera-Casanova,
Nerea Herrera‐Casanova,
Nerea M. Herrera-Casanova
Institutions:
Instituto Maimónides de Investigación Biomédica de Córdoba,
Hospital Universitario Reina Sofía,
Centro de Investigación Biomédica en Red de Cáncer,
University of Córdoba
Observed institutions:
Instituto Maimónides de Investigación Biomédica de Córdoba,
Hospital Universitario Reina Sofía,
Centro de Investigación Biomédica en Red de Cáncer,
University of Córdoba
ORCID:
0009-0004-5362-7349
Observed ORCID:
0009-0004-5362-7349
OpenAlex ID:
A5118119682
Glycolysis Inhibition Restores Immune Sensitivity in GSNOR–Deficient Colorectal Cancer
2025
·
Ana Mantrana
, María Teresa Sánchez-Montero
, et al.
·
Laboratory Investigation
·
4
Imbalanced NK cell subpopulations and TIGIT expression limit cetuximab efficacy in colorectal cancer: A promising target for treatment enhancement
2025
·
Carmen Navarrete‐Sirvent
, Ana Mantrana
, et al.
·
Clinical and Translational Medicine
·
3
PDF
Proteomic and immunophenotypic signatures reveal immune-mediated resistance to cetuximab in metastatic colorectal cancer
2026
·
Carmen Navarrete Sirvent
, Aurora Rivas-Crespo
, et al.
PDF
NR3C1 , LAX1 , and RCAN3 as Circulating Epigenetic Biomarkers for Prognosis and Chemotherapy Response Prediction in Metastatic Pancreatic Cancer
2026
·
Pablo Cano‐Ramírez
, Marta Toledano‐Fonseca
, et al.
·
MedComm
Show more works
View as search
Works count:
4
Citation count:
6
H-index:
2
I10-index:
Year
Topic
Type